MIRA INFORM REPORT

 

 

Report Date :

03.04.2007

 

IDENTIFICATION DETAILS

 

Name :

SIPRA LABS LIMITED

 

 

Registered Office :

407, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad – 500038, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

21.01.1994

 

 

Com. Reg. No.:

01-16912

 

 

CIN No.:

[Company Identification No.]

U85195AP1994PTC016912

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS03581E

 

 

Legal Form :

Closely held Public Limited Liability Company

 

 

Line of Business :

Wholesalers, Traders and Commission Traders, Except Motor Vehicles.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 640000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having satisfactory track. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

407, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad – 500038, Andhra Pradesh

Tel. No.:

91-40-23734720 / 23746873 / 874

Fax No.:

91-40-23746871

E-Mail :

sipra@sipralabs.com

Website :

http://www.sipralabs.com

 

 

DIRECTORS

 

Name :

Mr. V. Satyanarayana

Designation :

Chairman & Managing Director

Address :

D – 101, Aditya Enclave, Ameerpet, Hyderabad – 500038, Andhra Pradesh

Date of Birth/Age :

27.10.1960

Date of Appointment :

21.01.1994

 

 

Name :

Mr. V. Srihari

Designation :

Director

Address :

D – 14, Usodaya Complex, Tarnaka, Secunderabad, Andhra Pradesh

Date of Birth/Age :

11.06.1961

Date of Appointment :

21.01.1994

 

 

Name :

Mr. A. Siva Ram Prasad

Designation :

Director

Address :

Plot No. 12, Shanthi Apartments, Tarnaka, Secunderabad, Andhra Pradesh

Date of Birth/Age :

18.12.1965

Date of Appointment :

21.01.1994

 

 

Name :

Ms. V. Madhavi

Designation :

Director

Address :

D – 101, Aditya Enclave, Ameerpet, Hyderabad – 500038, Andhra Pradesh

Date of Birth/Age :

19.03.1963

Date of Appointment :

03.07.1998

 

 

Name :

Mr. V. Sitarama Swamy

Designation :

Director

Address :

S – 3, Krishnaveni Arcade, Kapra, Secunderabad, Andhra Pradesh

Date of Birth/Age :

05.06.19954

Date of Appointment :

29.05.2004

 


 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Mr. V. Satyanarayana

 

1111900

Mr. V. Sri Hari

 

129500

Mr. A. Sivaram Prasad

 

10000

Mr. V. Sitaravamma

 

143000

Mr. A. Laxmi

 

50000

Mr. V. Rajya Lakshmi

 

64000

Mr. V. Hemalatha Bhaskar

 

77000

Mr. V. Srinivasa Rao

 

126066

Mr. TSR. Swamy

 

50800

Mr. V. Sri Rama

 

83600

Mr. A. Sitaram Prasad

 

128000

Ms. V. Madhavi

 

324925

Mr. V. Sri Padma

 

108000

Ms. K. Kamalabai

 

20000

Mr. V. Sri Ram

 

23785

Mr. V. Sri Harsha

 

26000

Mr. V. Poornachandra Rao

 

31000

Mr. V. Swaroop

 

15000

Mr. A. Vijaya Lakshmi

 

53000

Mr. M. Srinivas Rao

 

2500

Mr. K. Srinivas Rao

 

2500

Mr. K. Sreedhar

 

2500

Mr. G. Nageswara Rao

 

2500

Mr. G. Sitaratnam

 

30000

Mr. J. Sita

 

15000

Mr. S. Surekha

 

5000

Mr. V. Sri Teja

 

17500

Mr. Lalit Vaya

 

1000

Mr. A. Maheswara Reddy

 

1000

Mr. P. Laxamana Rao

 

1000

Dr. Raj Philip

 

1000

Mr. Saroop Kumar

 

1000

Mr. D. Venugopal

 

700

Mr. R. Shyam Sundhar

 

500

Mr. I. Bhanu Prakash

 

500

Ms. P. Saritha Yadav

 

500

Ms. A. Saradha Rani

 

500

Mr. P. K. Desh Pridesh

 

500

Mr. A. Narayana Swamy

 

500

Mr. S. V. Mohan Naik

 

250

TOTAL

 

2662026

 

All the shares are held by the Directors and relatives of directors.

 

BUSINESS DETAILS

 

Line of Business :

Wholesalers, Traders and Commission Traders, Except Motor Vehicles.

 

 

Products :

Testing and Services Charges

 


 

GENERAL INFORMATION

 

No. of Employees :

About 75

 

 

Bankers :

Canara Bank

 

 

Financial Institutions :

A.P.S.F.C.

 

 

Facilities :

Secured Loans :

A.P.S.F.C. Loan : Rs.28.200 millions

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Paturi & Associates

Charteres Accountants

Address :

203, Crystal Residency, Jayaprakash Nagar, Opposite Lane State House Bus Stop, Yellareddyguda, Hyderabad – 500073, Andhra Pradesh, India

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

500000

Equity Shares

Rs.100/- each

Rs.50.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

3405026

Equity Shares

Rs.10/- each

Rs.34.050 millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2006

31.03.2005

31.03.2004

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

34.050

27.180

21.280

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

126.907

55.085

18.448

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

160.957

82.265

39.728

LOAN FUNDS

 

 

 

1] Secured Loans

18.000

28.200

0.418

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

18.000

28.200

0.418

DEFERRED TAX LIABILITIES

13.357

16.881

3.669

 

 

 

 

TOTAL

192.314

127.346

43.815

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

100.722

105.172

50.337

Capital work-in-progress

51.936

0.000

0.000

 

 

 

 

INVESTMENT

1.973

4.208

0.320

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.548

0.521

0.401

 

Sundry Debtors

37.853

28.435

18.046

 

Cash & Bank Balances

10.486

12.760

9.602

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

13.501

3.615

7.334

Total Current Assets

62.388

45.331

35.383

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities & Provisions

24.705

27.365

42.225

Total Current Liabilities

24.705

27.365

42.225

Net Current Assets

37.683

17.966

[6.842]

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

192.314

127.346

43.815

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2006

31.03.2005

31.03.2004

Sales Turnover

143.001

137.548

90.197

Other Income

1.786

0.552

0.006

Total Income

144.787

135.100

90.203

 

 

 

 

Profit/(Loss) Before Tax

73.454

63.440

15.409

Provision for Taxation

0.000

23.403

5.484

Profit/(Loss) After Tax

73.454

40.037

9.925

 

 

 

 

Total Earnings

NA

9.834

3.731

 

 

 

 

Total Imports

NA

0.128

0.000

 

 

 

 

Expenditures :

 

 

 

 

Administrative Expenses

NA

NA

26.435

 

Raw Material Consumed

9.386

15.819

21.331

 

Salaries, Wages, Bonus, etc.

14.509

12.698

11.314

 

Financial Charges

NA

NA

0.373

 

Depreciation & Amortization

10.603

9.571

6.348

 

Other Expenditure

36.835

33.572

8.992

Total Expenditure

71.333

71.660

74.794

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2006

31.03.2005

31.03.2004

PAT / Total Income

(%)

50.73

29.63

11.00

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

50.73

46.96

17.08

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

45.03

42.15

17.97

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.46

0.77

0.39

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.26

0.67

1.07

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.52

1.66

0.84

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Form 8 Particular for creation or modification of charges 

 

Corporation identity number or foreign company registrations number of the company 

U85195AP1994PTC016912

Name of the company

SIPRA LABS LIMITED

Address

407, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad – 500038, Andhra Pradesh

This Form is for

Creation of charge

Type of Charges

Equitable mortgage or mortgage of property by depositing the title deeds

Particular of the charge holder 

State Bank of India

Overseas Branch,

5-9-300, ABIDS, Hyderabad-500001

Andhra Pradesh, India

Nature or description of the instrument creating charge  

Agreement of loan for overall limits

Agreement of hypothecation of goods

Agreement of pledge of goods and assets

Deed of guarantees for overall limit

Form C-5 and Form C-9

Date of the instrument creating charge

18.02.2006

Amount Secure by the charge

Rs.151.800 millions

Brief of the principal terms and conditions and extent and operation of the charge

Fund based Rs.145 millions and non fund based Rs.6.800 millions total 151.800 millions. Repayment in 6 years in 20 quarters of Rs.7.25 millions each commencing from 01.04.2007. The interest is 9% fixed with reset at the end of every second year.

Description of the property charge whether it is a charge on

Immovable properties

Modification charge

Charge identification number of the charge to be modified

 

Date of instrument modifying the charge

 

Particulars of the Property charged  

First charge on fixed assets if Unit II at 7-2-1813/5/A, 59/6 Sanathnagar Industrial Estate, Sanathnagar, Hyderabad

 

Second charge on the fixed assets of unit I situated at 407, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad-38.

 

Company’s fixed assets include Land, Building, Machinery, Electrical fittings, Lab Equipments, Furniture and Fixtures, Vehicles, Computer and Electric Items and Advance for land.

 

 

Website Details :

 

SIPRA Labs is a Government. approved and ISO-9001:2000 Certified state-of-the-art Pharmaceutical / Analytical laboratory set up for providing specialised services for

 

v      Bio-Availability

v      Bio-Equivalence

v      Stability and method development studies

 

 

The other major thrust areas of SIPRA Labs are Research and Development of Pharmaceuticals and Drug Intermediates.

 

Impurity profile estimation, Study of Drug release patterns and Environmental Impact Assessment studies.

 

In order to meet all the above requirements of their clients, SIPRA Labs set up its facilities at Hyderabad, the nerve center for Indian Drug Industry, with a capital outlay of Rs. 25 million. It is well equipped with state-of-the-art electronic instruments and an experienced team of young and enthusiastic scientists for providing professional services in the field of Drugs, Pharmaceuticals, Chemicals, Foods, Process wastes and environmental studies.
 

Sipra Labs adheres to the following quality standards:

 

v      Indian Pharmacopoeia - IP

v      US Pharmacopoeia - USP

v      British Pharmacopoeia - BP

v      European Pharmacopoeia - EP

v      Japanese Pharmacopoeia - JP

v      Association of American Chemists – AOAC

v      Bureau of Indian Standards - BIS

v      ISO 9002 Standards (Australia, Quality Assurance Services)

v      Drug Control Administration (Government of India)

v      Good Laboratory Practices Recognized Research Institution,

v      Andhra University - Waltair

v      DST Accreditation
 

Awards:


They received several awards from the chemical and pharmaceutical industry in recognition of high quality service.

 

v      ISO 9002 certification from Bureau Veritas Quality International.

v      The Drug Controller General (India) approval for conducting Bio-Availability & Bio-Equivalence studies for new drugs.

v      Approved by Drug Control Administration Govt. of Andhra Pradesh & India. as a testing laboratory.

v      Procedures for getting the approval from Andhra Pradesh Pollution Control Board, Hyderabad

v      Recognised as a research center by some Indian Universities

 

Clients

 

Multinational Corporations

             

v      Johnson & Johnson Limited

v      Proctor & Gamble India Limited

v      Parke-Davis India Limited

v      Knoll Pharmaceuticals India Limited

v      Novartis Nutrition (India) Private Limited

v      Astra-IDL Limited

v      ICI India Limited

v      Uni Sankyo Limited

v      Wyeth Lederle Limited

v      Nicholas Piramal Limited

v      Fulford India Limited

 

Indian National Corporations    

 

v      Aurobindo Pharma Limited

v      Core Parenterals Limited

v      Dr. Reddy's Labs Limited

v      Geoffrey Manners & Company Limited

v      Gland Pharma Limited

v      Max Pharma.

v      Natco Pharma Limited

v      Neuland Laboratories Limited

v      N.R. Jet Enterprises.

v      Orchid Chemicals & Pharmaceuticals Limited

v      Ranbaxy Laboratories Limited

v      Sang Froid Pharma India Limted

v      Siris Limited

v      Sun Pharmaceutical Works Limited

v      Suven Pharmaceuticals Limited

v      Torrent Pharmaceuticals Limited

v      Triton Laboratories Limited

v      T.T.K Pharma Limited

v      Veer Chemie & Aromatics Limited

v      Vorin Laboratories Limited

 

Public Sector Undertakings

           

v      Kerala State Drugs & Pharmaceuticals Limited

v      Maharashtra Antibiotics & Pharma Limited

v      Goa Antibiotics & Pharmaceuticals Limited

v      Indian Immunologicals Limited
 

Government Departments

 

v      Govt Medical Stores Depot, Hyderabad, Chennai, Mumbai, New Delhi.

v      AP Vaidya Vidhana Parishad, Hyderabad.

v      Dept of Woman and Child Welfare, Hyderabad.

v      South Central Railways, Hyderabad.

v      TN Medical Services Corp, Chennai

v      Dept of Health and Family Welfare, Orissa
 

Accreditations

 

v      DSIR – recognized in-house R & D Unit(s).

v      ISO 9001:2000 (QAS Australia)

v      NABL (ISO / IEC 17025:1999)

v      CPCSEA (Ministry of Social Justice, Government of India)

v      Drugs Controller General of India (DCGI)

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.42.90

UK Pound

1

Rs.84.69

Euro

1

Rs.57.21

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions